Reply: Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer Letter uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antineoplastic Combined Chemotherapy Protocols
  • Fibroblasts
  • Pancreatic Neoplasms

publication date

  • January 2014

Research

keywords

  • Letter

Identity

Language

  • eng

PubMed Central ID

  • PMC4200079

Digital Object Identifier (DOI)

  • 10.1038/bjc.2014.129

PubMed ID

  • 24642623

Additional Document Info

start page

  • 1677

end page

  • 8

volume

  • 111

number

  • 8